Literature DB >> 12744619

Future perspectives on malignant melanoma.

Stanley P L Leong1.   

Abstract

Emphasis for the treatment of melanoma should be shifted more to prevention and early diagnosis, because early melanoma may potentially be cured in most cases. Clinical trials are important to establish more effective adjuvant modalities against melanoma. Multifaceted aspects of micrometastasis, including differentiation of different clones with respect to the primary tumor, acquisition of adhesion molecules, and host interaction with the microscopic tumor, will shed new light on the biology and mechanism of early metastasis. New molecular and genetic tools may be used to dissect the mechanisms of lymphatic and hematogenous routes of metastasis. If such mechanisms can be understood, potential therapeutic maneuvers can be developed to prevent the process of micrometastasis.

Entities:  

Mesh:

Year:  2003        PMID: 12744619     DOI: 10.1016/S0039-6109(02)00204-9

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

1.  The antimelanoma immunocytokine scFvMEL/TNF shows reduced toxicity and potent antitumor activity against human tumor xenografts.

Authors:  Yuying Liu; Weihe Zhang; Lawrence H Cheung; Ting Niu; Qingping Wu; Chun Li; Carolyn S Van Pelt; Michael G Rosenblum
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

2.  National Practice Patterns in the Management of the Regional Lymph Node Basin After Positive Sentinel Lymph Node Biopsy for Cutaneous Melanoma.

Authors:  Cimarron E Sharon; Richard J Straker; Eric H Li; Giorgos C Karakousis; John T Miura
Journal:  Ann Surg Oncol       Date:  2022-08-25       Impact factor: 4.339

Review 3.  WITHDRAWN: Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.

Authors:  Andre D Sasse; Emma C Sasse; Luciana Go Clark; Otavio Augusto Camara Clark
Journal:  Cochrane Database Syst Rev       Date:  2018-02-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.